These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38130541)

  • 21. Th1-skewed profile and excessive production of proinflammatory cytokines in a NFKB1-deficient patient with CVID and severe gastrointestinal manifestations.
    Dieli-Crimi R; Martínez-Gallo M; Franco-Jarava C; Antolin M; Blasco L; Paramonov I; Semidey ME; Álvarez Fernández A; Molero X; Velásquez J; Martín-Nalda A; Pujol-Borrell R; Colobran R
    Clin Immunol; 2018 Oct; 195():49-58. PubMed ID: 30063981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of refractory cytomegalovirus-related thrombocytopenia that achieved complete remission without antiviral therapy.
    Nishio Y; Kawano Y; Kawada JI; Ito Y; Hara S
    J Infect Chemother; 2018 Dec; 24(12):995-997. PubMed ID: 30001843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Idiopathic thrombocytopenic purpura in children].
    Gebauer E; Vijatov G
    Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel NFKB1 variant in a Japanese pedigree with common variable immunodeficiency.
    Nakatani N; Tamura A; Hanafusa H; Nino N; Yamamoto N; Awano H; Tanaka Y; Morisada N; Uemura S; Saito A; Hasegawa D; Nozu K; Kosaka Y
    Hum Genome Var; 2024 Mar; 11(1):15. PubMed ID: 38514645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Pathogenic Missense Variant in
    Fliegauf M; Krüger R; Steiner S; Hanitsch LG; Büchel S; Wahn V; von Bernuth H; Grimbacher B
    Front Immunol; 2021; 12():621503. PubMed ID: 33995346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is It a Coincidence or Secondary Immune Thrombocytopenic Purpura? A Case of an 11-Year-Old Male Patient at Hawassa University Comprehensive Specialized Hospital, Hawassa, Sidama, Ethiopia.
    Ketema W; Taye K; Tagesse N; Eifa A
    Int Med Case Rep J; 2022; 15():85-90. PubMed ID: 35283650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. JAK2 V617F-positive essential thrombocythemia with subsequent development of immune thrombocytopenia: A case report.
    Oda Y; Sato S; Kanbe E; Kamata W; Okada S; Tamai Y
    Medicine (Baltimore); 2019 Nov; 98(44):e17766. PubMed ID: 31689837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic predictive value of platelet indices for discriminating hypo productive versus immune thrombocytopenia purpura in patients attending a tertiary care teaching hospital in Addis Ababa, Ethiopia.
    Negash M; Tsegaye A; G/Medhin A
    BMC Hematol; 2016; 16():18. PubMed ID: 27375850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CVID-Associated Tumors: Czech Nationwide Study Focused on Epidemiology, Immunology, and Genetic Background in a Cohort of Patients With CVID.
    Kralickova P; Milota T; Litzman J; Malkusova I; Jilek D; Petanova J; Vydlakova J; Zimulova A; Fronkova E; Svaton M; Kanderova V; Bloomfield M; Parackova Z; Klocperk A; Haviger J; Kalina T; Sediva A
    Front Immunol; 2018; 9():3135. PubMed ID: 30723478
    [No Abstract]   [Full Text] [Related]  

  • 30. Wiskott-Aldrich syndrome that was initially diagnosed as immune thrombocytopenic purpura secondary to a cytomegalovirus infection.
    Kaneko R; Yamamoto S; Okamoto N; Akiyama K; Matsuno R; Toyama D; Hoshino A; Imai K; Isoyama K
    SAGE Open Med Case Rep; 2018; 6():2050313X17753788. PubMed ID: 29348920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concurrence of immune thrombocytopenic purpura and thrombotic thrombocytopenic purpura: a case report and review of the literature.
    Lin HC; Huang J; Huang J; Zhang LJ; Yin XW; Yang JC; Huang XY
    J Med Case Rep; 2023 Feb; 17(1):38. PubMed ID: 36750960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors associated with neonatal thrombocytopenia in pregnant women with immune thrombocytopenic purpura.
    Rottenstreich A; Israeli N; Roth B; Elchalal U; Amsalem H; Da'as N; Rottenstreich M; Kalish Y
    J Matern Fetal Neonatal Med; 2020 May; 33(9):1572-1578. PubMed ID: 30209963
    [No Abstract]   [Full Text] [Related]  

  • 33. "Immune" Thrombocytopenia as Key Feature of a Novel ADA2 Deficiency Variant: Implication on Differential Diagnostics of ITP in Children.
    Sundin M; Marits P; Nierkens S; Kolios AGA; Nilsson J
    J Pediatr Hematol Oncol; 2019 Mar; 41(2):155-157. PubMed ID: 29620681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Refractory immune thrombocytopenia in adults: Towards a new definition.
    Arnold DM; Clerici B; Ilicheva E; Ghanima W
    Br J Haematol; 2023 Oct; 203(1):23-27. PubMed ID: 37642211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CLINICAL RELEVANCE OF EXTENDED PLATELET INDICES IN THE DIAGNOSIS OF IMMUNE THROMBOCYTOPENIA.
    Arshad A; Mukry SN; Shamsi TS
    Acta Clin Croat; 2021 Dec; 60(4):665-674. PubMed ID: 35734488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful eltrombopag treatment of severe refractory thrombocytopenia in chronic myelomonocytic leukemia: Two cases reports: A CARE-compliant article.
    Gao Y; Gong M; Zhang C; Kong X; Ma Y
    Medicine (Baltimore); 2017 Oct; 96(43):e8337. PubMed ID: 29069007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistent Relapsing Immune Thrombocytopenia Following COVID-19 Infection.
    Boehm BA; Packer CD
    Cureus; 2022 Jul; 14(7):e27133. PubMed ID: 36004011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune Thrombocytopenia (ITP): Current Limitations in Patient Management.
    Terrell DR; Neunert CE; Cooper N; Heitink-Pollé KM; Kruse C; Imbach P; Kühne T; Ghanima W
    Medicina (Kaunas); 2020 Nov; 56(12):. PubMed ID: 33266286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Secondary ITP in adults].
    Michel M; Lega JC; Terriou L
    Rev Med Interne; 2021 Jan; 42(1):50-57. PubMed ID: 33139079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A gain-of-function mutation in TNFRSF13B is a candidate for predisposition to familial or sporadic immune thrombocytopenia.
    Peng HL; Zhang Y; Sun NN; Yin YF; Wang YW; Cheng Z; Yan WZ; Liu SF; Xu YX; Xiao X; Zhang GS
    J Thromb Haemost; 2017 Nov; 15(11):2259-2269. PubMed ID: 28834165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.